| 1 |
34536415 | Early-onset pulmonary and cutaneous vasculitis driven by constitutively active SRC-family kinase HCK. | 2022 Apr |
1 |
| 2 |
34687791 | Induction of IL-6Rα by ATF3 enhances IL-6 mediated sorafenib and regorafenib resistance in hepatocellular carcinoma. | 2022 Jan 1 |
1 |
| 3 |
33382511 | STAT3 and its targeting inhibitors in osteosarcoma. | 2021 Feb |
1 |
| 4 |
34290255 | Stromal induction of BRD4 phosphorylation Results in Chromatin Remodeling and BET inhibitor Resistance in Colorectal Cancer. | 2021 Jul 21 |
1 |
| 5 |
34390807 | The anti-parallel dimer binding interface in STAT3 transcription factor is required for the inactivation of cytokine-mediated signal transduction. | 2021 Nov |
1 |
| 6 |
34703823 | STAT3 as a Potential Target for Tumor Suppressive Effects of 15-Deoxy-Δ12,14-prostaglandin J2 in Triple Negative Breast Cancer. | 2021 Sep 30 |
1 |
| 7 |
31068940 | CD28 Individual Signaling Up-regulates Human IL-17A Expression by Promoting the Recruitment of RelA/NF-κB and STAT3 Transcription Factors on the Proximal Promoter. | 2019 |
1 |
| 8 |
31080186 | Fraxetin Suppresses Proliferation of Non-Small-Cell Lung Cancer Cells via Preventing Activation of Signal Transducer and Activator of Transcription 3. | 2019 May |
1 |
| 9 |
28558479 | Mechanisms of Mitochondrial Redox Signaling in Psychosocial Stress-Responsive Systems: New Insights into an Old Story. | 2018 Mar 20 |
1 |
| 10 |
29456111 | Methyllucidone inhibits STAT3 activity by regulating the expression of the protein tyrosine phosphatase MEG2 in DU145 prostate carcinoma cells. | 2018 Mar 1 |
2 |
| 11 |
29581268 | IRF9 and unphosphorylated STAT2 cooperate with NF-κB to drive IL6 expression. | 2018 Apr 10 |
2 |
| 12 |
29660364 | Silibinin is a direct inhibitor of STAT3. | 2018 Jun |
1 |
| 13 |
29807795 | Piperlongumine derivative, CG-06, inhibits STAT3 activity by direct binding to STAT3 and regulating the reactive oxygen species in DU145 prostate carcinoma cells. | 2018 Aug 1 |
1 |
| 14 |
28208810 | Shp2 Plays a Critical Role in IL-6-Induced EMT in Breast Cancer Cells. | 2017 Feb 13 |
1 |
| 15 |
28722170 | Activation of the B-cell receptor successively activates NF-κB and STAT3 in chronic lymphocytic leukemia cells. | 2017 Nov 15 |
3 |
| 16 |
26423306 | Serum Phenylalanine, Tyrosine, and their Ratio in Acute Ischemic Stroke: on the Trail of a Biomarker? | 2016 Jan |
1 |
| 17 |
26893580 | Interleukin-6 is a potential therapeutic target in interleukin-6 dependent, estrogen receptor-α-positive breast cancer. | 2016 |
1 |
| 18 |
27048653 | A New STAT3-binding Partner, ARL3, Enhances the Phosphorylation and Nuclear Accumulation of STAT3. | 2016 May 20 |
1 |
| 19 |
27502766 | Mitochondrial STAT3 is negatively regulated by SOCS3 and upregulated after spinal cord injury. | 2016 Oct |
1 |
| 20 |
26166037 | Homoharringtonine induces apoptosis and inhibits STAT3 via IL-6/JAK1/STAT3 signal pathway in Gefitinib-resistant lung cancer cells. | 2015 Jul 13 |
1 |
| 21 |
26384335 | Effects of Reducing Suppressors of Cytokine Signaling-3 (SOCS3) Expression on Dendritic Outgrowth and Demyelination after Spinal Cord Injury. | 2015 |
2 |
| 22 |
26572585 | Role of Integrin β4 in Lung Endothelial Cell Inflammatory Responses to Mechanical Stress. | 2015 Nov 17 |
1 |
| 23 |
23032719 | Evodiamine inhibits STAT3 signaling by inducing phosphatase shatterproof 1 in hepatocellular carcinoma cells. | 2013 Jan 28 |
6 |
| 24 |
23166300 | TCPTP regulates SFK and STAT3 signaling and is lost in triple-negative breast cancers. | 2013 Feb |
2 |
| 25 |
23303450 | The IL-6 trans-signaling-STAT3 pathway mediates ECM and cellular proliferation in fibroblasts from hypertrophic scar. | 2013 May |
1 |
| 26 |
23583378 | Metastasis suppressor Nm23-H1 inhibits STAT3 signaling via a negative feedback mechanism. | 2013 May 10 |
1 |
| 27 |
23906537 | The Fer tyrosine kinase acts as a downstream interleukin-6 effector of androgen receptor activation in prostate cancer. | 2013 Dec 5 |
1 |
| 28 |
24082147 | STAT3 activation in response to IL-6 is prolonged by the binding of IL-6 receptor to EGF receptor. | 2013 Oct 15 |
1 |
| 29 |
24152848 | Novel path to IL-6 trans-signaling through thrombin-induced soluble IL-6 receptor release by platelets. | 2013 Jul-Sep |
2 |
| 30 |
24192293 | Dominant-negative activity of the STAT3-Y705F mutant depends on the N-terminal domain. | 2013 Nov 5 |
1 |
| 31 |
21954831 | Interleukin-6 autocrine signaling mediates melatonin MT(1/2) receptor-induced STAT3 Tyr(705) phosphorylation. | 2012 May |
2 |
| 32 |
22197944 | STAT3 genotypic variation and cellular STAT3 activation and colon leukocyte recruitment in pediatric Crohn disease. | 2012 Jul |
1 |
| 33 |
22280969 | Diindolylmethane suppresses ovarian cancer growth and potentiates the effect of cisplatin in tumor mouse model by targeting signal transducer and activator of transcription 3 (STAT3). | 2012 Jan 26 |
1 |
| 34 |
23125416 | CCR1-mediated STAT3 tyrosine phosphorylation and CXCL8 expression in THP-1 macrophage-like cells involve pertussis toxin-insensitive Gα(14/16) signaling and IL-6 release. | 2012 Dec 1 |
1 |
| 35 |
20978825 | Adiponectin reduces C-reactive protein expression and downregulates STAT3 phosphorylation induced by IL-6 in HepG2 cells. | 2011 Jan |
1 |
| 36 |
21216930 | JAK1 activates STAT3 activity in non-small-cell lung cancer cells and IL-6 neutralizing antibodies can suppress JAK1-STAT3 signaling. | 2011 Mar |
1 |
| 37 |
21625522 | Dynamics of the STAT3 transcription factor: nuclear import dependent on Ran and importin-β1. | 2011 |
1 |
| 38 |
21625597 | Two naturally occurring terpenes, dehydrocostuslactone and costunolide, decrease intracellular GSH content and inhibit STAT3 activation. | 2011 |
1 |
| 39 |
21690253 | Somatic mutations activating STAT3 in human inflammatory hepatocellular adenomas. | 2011 Jul 4 |
1 |
| 40 |
20233902 | Sulforaphane inhibits constitutive and interleukin-6-induced activation of signal transducer and activator of transcription 3 in prostate cancer cells. | 2010 Apr |
2 |
| 41 |
20379953 | Kansuinine A and Kansuinine B from Euphorbia kansui L. inhibit IL-6-induced Stat3 activation. | 2010 Oct |
1 |
| 42 |
20383201 | Dasatinib inhibits site-specific tyrosine phosphorylation of androgen receptor by Ack1 and Src kinases. | 2010 Jun 3 |
3 |
| 43 |
20693312 | Glucocorticoids potentiate IL-6-induced SP-B expression in H441 cells by enhancing the JAK-STAT signaling pathway. | 2010 Oct |
1 |
| 44 |
20724373 | Withaferin A inhibits activation of signal transducer and activator of transcription 3 in human breast cancer cells. | 2010 Nov |
2 |
| 45 |
20728433 | Identification of BCAP-(L) as a negative regulator of the TLR signaling-induced production of IL-6 and IL-10 in macrophages by tyrosine phosphoproteomics. | 2010 Sep 17 |
1 |
| 46 |
20851386 | Neutralization of interleukin (IL)-10 released by monocytes/macrophages enhances the up-regulatory effect of monocyte/macrophage-derived IL-6 on expressions of IL-6 and MUC1, and migration in HT-29 colon cancer cells. | 2010 |
1 |
| 47 |
20876575 | Suppressor of cytokine signaling 3 inhibits LPS-induced IL-6 expression in osteoblasts by suppressing CCAAT/enhancer-binding protein {beta} activity. | 2010 Nov 26 |
1 |
| 48 |
18988672 | S-glutathionylation impairs signal transducer and activator of transcription 3 activation and signaling. | 2009 Mar |
1 |
| 49 |
19009233 | The fungal secondary metabolite trichodimerol inhibits TGF-β dependent cellular effects and tube formation of MDA-MB-231 cells. | 2009 Dec |
1 |
| 50 |
19182994 | Ha-ras oncogene-induced Stat3 phosphorylation enhances oncogenicity of the cell. | 2009 Mar |
2 |